Catherine Bollard, M.D., is the CEO of Cabaletta Bio, Inc., and has a rich background in medicine, particularly in cancer and immunology. She has been shaping the future of cell therapy as the Director of the Center for Cancer and...
Catherine Bollard, M.D., is the CEO of Cabaletta Bio, Inc., and has a rich background in medicine, particularly in cancer and immunology. She has been shaping the future of cell therapy as the Director of the Center for Cancer and Immunology Research at the Children’s National Health System. Dr. Bollard has extensive experience, having served as a Professor at George Washington University and worked with the FDA on cell therapies. She's also been a leader in organizations like the International Society for Cell Therapy. Even though her annual salary is around $480,500, there are no bonuses or stock awards in her compensation package for 2023. Notably, she was involved in the creation of the Science and Technology Committee at Cabaletta, showcasing her commitment to guiding research efforts. Her role is vital in steering the company through challenges, and her medical expertise plays a key part in deciding the future of innovative treatments for patients. She brings a mix of academic prowess and hands-on leadership into her position, influencing both company strategy and scientific advancement.